Meeting the rising tide of chronic disease - Trend Talk
Responsible for 63% of all deaths, non-communicable diseases will cost the world $30 trillion by 2030. Not only did the pandemic delay care for chronic disease patients, but it brought about further democratization of testing. Patients with liver disease, kidney disease, diabetes and allergies are taking command of their health. Clinicians are looking for tools for risk assessment.
Learn how testing accuracy and accessibility can help unlock a lab’s ability to evaluate patients impacted by this growing epidemic.